These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38900374)

  • 41. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human Brain Endothelial CXCR2 is Inflammation-Inducible and Mediates CXCL5- and CXCL8-Triggered Paraendothelial Barrier Breakdown.
    Haarmann A; Schuhmann MK; Silwedel C; Monoranu CM; Stoll G; Buttmann M
    Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30704100
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Analysis of CXCL8 and its receptors CXCR1/CXCR2 at the mRNA level in neoplastic tissue, as well as in serum and peritoneal fluid in patients with ovarian cance.
    Smycz-Kubańska M; Stępień S; Gola JM; Kruszniewska-Rajs C; Wendlocha D; Królewska-Daszczyńska P; Strzelec A; Strzelczyk J; Szanecki W; Witek A; Mielczarek-Palacz A
    Mol Med Rep; 2022 Oct; 26(4):. PubMed ID: 35920183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Structural insights into the activation of chemokine receptor CXCR2.
    Liu K; Shen L; Wu M; Liu ZJ; Hua T
    FEBS J; 2022 Jan; 289(2):386-393. PubMed ID: 33835690
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin 8 (CXCL8)-CXC chemokine receptor 2 (CXCR2) axis contributes to MiR-4437-associated recruitment of granulocytes and natural killer cells in ischemic stroke.
    He Q; Shi X; Zhou B; Teng J; Zhang C; Liu S; Lian J; Luo B; Zhao G; Lu H; Xu Y; Lian Y; Jia Y; Zhang Y
    Mol Immunol; 2018 Sep; 101():440-449. PubMed ID: 30096583
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Multiple anti-tumor effects of Reparixin on thyroid cancer.
    Liotti F; De Pizzol M; Allegretti M; Prevete N; Melillo RM
    Oncotarget; 2017 May; 8(22):35946-35961. PubMed ID: 28415590
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Serum chemokine CXCL8 as a better biomarker for diagnosis and prediction of pancreatic cancer than its specific receptor CXCR2, C-reactive protein, and classic tumor markers CA 19-9 and CEA.
    Litman-Zawadzka A; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Pol Arch Intern Med; 2018 Sep; 128(9):524-531. PubMed ID: 30057378
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CXCL8 expression is associated with advanced stage, right sidedness, and distinct histological features of colorectal cancer.
    Pennel KA; Quinn JA; Nixon C; Inthagard J; van Wyk HC; Chang D; Rebus S; ; Hay J; Maka NN; Roxburgh CS; Horgan PG; McMillan DC; Park JH; Roseweir AK; Steele CW; Edwards J
    J Pathol Clin Res; 2022 Nov; 8(6):509-520. PubMed ID: 35879507
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potentiation of inflammatory CXCL8 signalling sustains cell survival in PTEN-deficient prostate carcinoma.
    Maxwell PJ; Coulter J; Walker SM; McKechnie M; Neisen J; McCabe N; Kennedy RD; Salto-Tellez M; Albanese C; Waugh DJ
    Eur Urol; 2013 Aug; 64(2):177-88. PubMed ID: 22939387
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CXCL8 Associated Dendritic Cell Activation Marker Expression and Recruitment as Indicators of Favorable Outcomes in Colorectal Cancer.
    Li E; Yang X; Du Y; Wang G; Chan DW; Wu D; Xu P; Ni P; Xu D; Hu Y
    Front Immunol; 2021; 12():667177. PubMed ID: 34025668
    [TBL] [Abstract][Full Text] [Related]  

  • 51. CXCL8-induced FAK phosphorylation via CXCR1 and CXCR2: cytoskeleton- and integrin-related mechanisms converge with FAK regulatory pathways in a receptor-specific manner.
    Cohen-Hillel E; Yron I; Meshel T; Soria G; Attal H; Ben-Baruch A
    Cytokine; 2006 Jan; 33(1):1-16. PubMed ID: 16406804
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum CXCL8 and CXCR2 as diagnostic biomarkers for noninvasive screening of cervical cancer.
    Zhang N; Pang C; Li Z; Xu F; Zhao L
    Medicine (Baltimore); 2023 Aug; 102(34):e34977. PubMed ID: 37653753
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The activation of IL-8 receptors in cultured guinea pig Müller glial cells is modified by signals from retinal pigment epithelium.
    Malgorzata Goczalik I; Raap M; Weick M; Milenkovic I; Heidmann J; Enzmann V; Wiedemann P; Reichenbach A; Francke M
    J Neuroimmunol; 2005 Apr; 161(1-2):49-60. PubMed ID: 15748943
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer.
    Pawluczuk E; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
    Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680333
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of chemokine and chemokine receptor expression with the invasion and metastasis of lung carcinoma.
    Liu Y; Wu BQ; Geng H; Xu ML; Zhong HH
    Oncol Lett; 2015 Sep; 10(3):1315-1322. PubMed ID: 26622670
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.
    Heidemann J; Ogawa H; Dwinell MB; Rafiee P; Maaser C; Gockel HR; Otterson MF; Ota DM; Lugering N; Domschke W; Binion DG
    J Biol Chem; 2003 Mar; 278(10):8508-15. PubMed ID: 12496258
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Tumor-associated macrophages promote the metastatic potential of thyroid papillary cancer by releasing CXCL8.
    Fang W; Ye L; Shen L; Cai J; Huang F; Wei Q; Fei X; Chen X; Guan H; Wang W; Li X; Ning G
    Carcinogenesis; 2014 Aug; 35(8):1780-7. PubMed ID: 24608042
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Effects of Posttranslational Modifications of CXCL8/Interleukin-8 on CXCR1 and CXCR2 Internalization and Signaling Properties.
    Vacchini A; Mortier A; Proost P; Locati M; Metzemaekers M; Borroni EM
    Int J Mol Sci; 2018 Nov; 19(12):. PubMed ID: 30486423
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antitumor and Radiosensitization Effects of a CXCR2 Inhibitor in Nasopharyngeal Carcinoma.
    Liu X; Lan T; Mo F; Yang J; Wei Y; Wei X
    Front Cell Dev Biol; 2021; 9():689613. PubMed ID: 34124076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.